astrazeneca Archives – Cambridge Enterprise

Pioneering portfolio company Apollo Therapeutics closes $226.5 million round to translate fundamental medical research into medicines

06 September 2023

Apollo Therapeutics: KE Award Winners

Female scientist looking down a telescope

Apollo Therapeutics: Pioneering collaboration launches its next phase

10 February 2022

An update from Apollo Therapeutics

22 February 2017

Apollo: industry expertise and pharma muscle drives science to the clinic with unparalleled speed

09 February 2016

Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation

25 January 2016

Horizon Discovery announces collaboration with AstraZeneca

Astex starts Phase I study on new anti-cancer compound